TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,675,000 | +194.6% | 14,093 | -77.2% | 1.96% | +198.2% |
| Q4 2021 | $2,945,000 | -68.0% | 61,741 | -55.5% | 0.66% | -70.5% |
| Q3 2021 | $9,217,000 | -2.8% | 138,741 | +14.2% | 2.22% | -11.2% |
| Q2 2021 | $9,481,000 | +23.0% | 121,541 | +49.1% | 2.50% | +22.7% |
| Q1 2021 | $7,711,000 | -44.2% | 81,541 | -28.2% | 2.04% | -45.9% |
| Q4 2020 | $13,816,000 | +353.0% | 113,541 | +224.4% | 3.77% | +283.0% |
| Q3 2020 | $3,050,000 | +36.4% | 35,000 | 0.0% | 0.98% | +32.6% |
| Q2 2020 | $2,236,000 | +45.0% | 35,000 | 0.0% | 0.74% | +5.7% |
| Q1 2020 | $1,542,000 | -29.2% | 35,000 | 0.0% | 0.70% | -10.4% |
| Q4 2019 | $2,179,000 | – | 35,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |